Immunisation (vaccination)

12 months–18 y: 0.5 mL; ≥19 y: 1 mL — booster 6–12 months later

Primary series — birth to 19 y: 0.5 mL; ≥20 y: 1 mL (months 0, 1, 6)

0.5 mL IM — 9–14 y: 2 doses (0, 6–12 months); 15–45 y: 3 doses (0, 2, 6 months)

Children — primary 3 × 0.5 mL (2, 4 and 6–18 months) and a booster at 4–6 y

Unvaccinated adults at risk of exposure — 3 × 0.5 mL

Yearly — ≥6 months: 0.5 mL IM (6–35 months: 0.25 or 0.5 mL)

Infants from 2 months — 4 doses at 2, 4, 6 and 12 months

7–23 months — 2 doses (second in the 2nd year, ≥3 months after the first)

2–55 y — single 0.5 mL IM dose

Two 0.5 mL doses — at 12–15 months and 4–6 years

Infant — 0.5 mL at 2, 4, 6 and 12–15 months

Adults ≥18 y — one 0.5 mL dose

Pre-exposure — 1 mL IM on days 0 and 7 (or 0, 7 and 21/28)

Infants — 2 oral doses of 1.5 mL: from 6 weeks, ≥4 weeks apart, completed by 24 weeks

Prevention of RSV lower respiratory disease — ≥60 y, or 18–59 y at increased risk: single 0.5 mL dose

Booster — ≥10 y: 0.5 mL IM

Two 0.5 mL doses — 12 months–12 y: at 12–15 months and 4–6 y; ≥13 y: 4 weeks apart